Effectiveness of Transcranial Direct Current in Patients With Persistent COVID-19 With Headaches and Chronic Pain.

Fundación Universidad Católica de Valencia San Vicente Mártir

Status: Enrolling

Conditions: SARS CoV 2 Infection; Migraine Disorders; Chronic Pain; Persistent COVID-19; Headaches Chronic; Cluster Headache; Long Covid19; COVID-19; Post COVID-19 Condition; Myalgia; Long COVID; Post-COVID-19 Syndrome; Arthralgia

Treatments: Device: Transcranial Direct Current Therapy (tDCS)

Study type: Interventional

Funder types: Other

Identifiers

NCT05780450

UCV/2021-2022/140

Details and patient eligibility

About

This study aims to verify the efficacy / effectiveness of treatment with transcranial direct therapy (TDCS) in patients with Persistent Covid who present headaches, migraines and chronic pain, such as arthralgias and myalgias.

Transcranial Direct Therapy is used in the field of Physiotherapy and Rehabilitation, with results that prove to be effective for the treatment of patients suffering from symptoms such as migraines, headaches, chronic pain, fibromyalgia or chronic neuropathic pain.

As can be seen, in the case of patients with Persistent Covid we find several of these symptoms, so it is suggested that, if Transcranial Direct Current Therapy (TDCs) is giving such good results, relieving these symptoms, why can not give such good results and help so much in patients with Persistent Covid, If many of the symptoms are the same, even if the origin or cause is different.

Enrollment: 27 estimated patients

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with Persistent Covid
• Men and women
• All ages from 16 years old
• Patients who passed the Covid in its acute phase in an asymptomatic, mild and severe way.

Exclusion criteria

• Patients without confirmation with positive PCR in the acute phase of Covid-19
• Patients with Persistent Covid who do not have at least one of these symptoms: migraines, headaches, chronic pain, neuropathic pain, arthralgia, myalgias
• Patients with pacemaker / defibrillator
• Patients with brain implants
• Patients with cranial fractures
• Pregnant

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

27 participants in 1 patient group

Treatment group

Experimental group

Treatment:

Device: Transcranial Direct Current Therapy (tDCS)